Systematic Review and Meta-Analysis of Human Papillomavirus Prevalence and Genotypic Disparities Among Human Immunodeficiency Virus-Positive Women in Africa
Journal of Clinical Medicine · 22.08.2025 · 14 (17) · 5924
DOI: 10.3390/jcm14175924 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 22.08.2025. Verfasst von Yirga Amare und 3 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School of Medical Sciences, University of Pécs, Szigeti Str. 12, 7624 Pécs, Hungary. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the University of Pécs.
Abstract (Originalsprache)
Background
Human papillomavirus (HPV) is the most prevalent sexually transmitted infection with significant health implications, especially for women living with human immunodeficiency virus (HIV). The variability in reported prevalence and genotype distribution of HPV among HIV-positive women across different regions in Africa necessitates a comprehensive and systemic examination.
Methods
A systematic search was conducted across several databases. A random effect model was used to evaluate study heterogeneity through Q statistics and I2 measures. Publication bias was assessed using funnel plots and Egger’s tests. Risk factors for HPV among HIV-positive women were summarized qualitatively. This review was registered with PROSPERO: CRD42024525123.
Result
Twenty-three studies involving 9954 HIV-positive women were combined to estimate HPV prevalence. The overall prevalence of all HPV types was 49.4% (95% CI: 42.43, 56.38), with evidence of heterogeneity (Q = 520.92, df = 16, I2 = 96.93%, p < 0.0001). The prevalence of high-risk HPV was 45.26% (95% CI: 31.02, 59.91), showing heterogeneity across studies (Q = 439.18, df = 10, p < 0.0001, I2 = 97.72%). Low-risk HPV had a prevalence of 24.98% (95% CI: 12.27, 40.41), with variation among studies (Q = 134.39, df = 6, p < 0.0001, I2 = 95.54%). The most frequent genotypes were 16, 18, 52, 33, and 35. A higher cluster of differentiation 4 (CD4) count is associated with a lower prevalence of HPV.
Conclusions
The pooled HPV prevalence among HIV-positive women in Africa is lower compared to previous studies, but the slow decline poses challenges to meet the WHO’s goal of eliminating HPV-related cervical cancer by 2030. Therefore, enhanced prevention efforts, including HPV self-sampling, improved vaccination coverage, and early treatment interventions, are essential to meet the goal of eliminating HPV-related cervical cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Doctoral School of Medical Sciences, University of Pécs, Szigeti Str. 12, 7624 Pécs, Hungary.
- Doctoral School of Health Sciences, University of Pécs, Vörösmarty Str. 4, 7621 Pécs, Hungary.
- Department of Public Health, Medical School, University of Pécs, Szigeti Str. 12, 7624 Pécs, Hungary.
ORCID-Profile: Yirga Amare, Dahabo Gelgalo
Förderung
- the University of Pécs
Zitieren
APA
Amare, Y., Gelgalo, D., Pozsgai, É., & Kiss, I. (2025). Systematic Review and Meta-Analysis of Human Papillomavirus Prevalence and Genotypic Disparities Among Human Immunodeficiency Virus-Positive Women in Africa. Journal of Clinical Medicine, 14(17), 5924. https://doi.org/10.3390/jcm14175924
Vancouver
Amare Y, Gelgalo D, Pozsgai É, Kiss I. Systematic Review and Meta-Analysis of Human Papillomavirus Prevalence and Genotypic Disparities Among Human Immunodeficiency Virus-Positive Women in Africa. Journal of Clinical Medicine. 2025;14(17):5924. doi:10.3390/jcm14175924
BibTeX
@article{Amare2025,
author = {Amare, Yirga and Gelgalo, Dahabo and Pozsgai, Éva and Kiss, István},
title = {Systematic Review and Meta-Analysis of Human Papillomavirus Prevalence and Genotypic Disparities Among Human Immunodeficiency Virus-Positive Women in Africa},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {17},
pages = {5924},
doi = {10.3390/jcm14175924}
}
EUVIMED